Navigation Links
New book explores stem cell therapies for heart disease
Date:5/17/2011

WORCESTER, Mass. A new book edited by researchers at Worcester Polytechnic Institute (WPI) and the Stony Brook University School of Medicine provides a comprehensive look at the science and application of cellular therapies aimed at the leading cause of death---heart disease. "Regenerating the Heart: Stem Cells and the Cardiovascular System" (Humana Press) is edited by Glenn Gaudette, associate professor of biomedical engineering at WPI, and Ira Cohen, professor of physiology and biophysics at Stony Brook.

Recognized leaders in the field, Cohen and Gaudette have collaborated on cardiac regeneration research projects since 2002, when Gaudette was a faculty member at Stony Brook. Last year Humana Press asked the team to develop and edit the new book to serve as a foundational text for the emerging field. "We were fortunate to have leading investigators in this field, from around the word, contribute original material for this book," Gaudette said. "It's a book for clinicians, investigators, and graduate students who want to understand the history of the field, and to see where the science is today across all the major approaches of using stem cells to heal the beating heart."

According to the U.S. Centers for Disease Control and Prevention (CDC), heart disease is the leading killer of men and women, accounting for approximately one in four deaths in the United States each year. The CDC also reports that each year approximately 785,000 Americans have a first heart attack, while another 470,000 people who have already had one or more heart attacks have another. It is the magnitude of the potential impact on human health that motivated Gaudette and Cohen to focus on new therapies using stem cells to regenerate cardiac tissues damaged by heart attack or other diseases. "As we look forward to the twenty-first century, we see the potential of cell therapy to address many cardiovascular diseases," Cohen and Gaudette write in the book's introduction. "From heart failure, to atrioventricular nodal dysfunction (heart arrhythmia), the young but promising field of cell therapy is likely to play a significant role in developing a cure."

Gaudette is an expert on the mechanical aspects of cardiac function. His lab is exploring ways to coax bone marrowderived stem cells to regenerate cardiac muscle and improve the heart's ability to pump blood. Cohen, an expert on the electrical signals that regulate heart rhythms, is using bone marrowderived stem cells to develop an implantable biological pacemaker that could treat cardiac arrhythmias. In addition to editing the book, Cohen and Gaudette contributed chapters based on their own expertise.

The book is organized into four sections: boosting the heart's mechanical function, restoring normal heart rhythms, regenerating specific heart tissues like valves and blood vessels, and the emerging techniques being developed to deliver and assess various stem cells therapies for the heart. It includes chapters from three other WPI faculty members: Tanja Dominko, associate professor of biology and biotechnology, and Raymond Page and Marsha Rolle, assistant professors of biomedical engineering, wrote about work in their labs exploring various elements of tissue regeneration.

"We have learned greatly from the preparation of this text," Gaudette and Cohen write. "We thank the authors for their fine contributions and hope that [this book] contributes to the education of newly committed and veteran stem cells researchers alike."


'/>"/>

Contact: Michael Cohen
mcohen@wpi.edu
508-868-4778
Worcester Polytechnic Institute
Source:Eurekalert  

Related medicine news :

1. Research explores link between asthma and smoking
2. Research study explores gene therapy treatment to reduce symptoms of Parkinsons disease
3. OHSU physician explores method to reduce blood-clot risk in trauma patients
4. Study explores ability of professional dancers to return to their career after hip arthroscopy
5. Beyond Alzheimers: Research explores hippocampal sclerosis
6. Research explores lung cancer among pediatric cancer patients
7. New venture explores frontiers of personalized medicine
8. Animal Study Explores Potential Gene Therapy for Depression
9. New clinical trial explores role of vitamin D in preventing esophageal cancer
10. New research explores relief for xerostomia cancer patients
11. Study Explores Possibility of a Female Viagra
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
New book explores stem cell therapies for heart disease
(Date:3/28/2017)... ... March 28, 2017 , ... Public relations pros work hard to earn ... business channels. , While many results are clear, much of PR is hard to ... When it comes to measurement, firms should always take an all-inclusive approach that takes ...
(Date:3/28/2017)... ... ... skin is a common and unwelcomed occurrence in people of all ages, genders and ethnicities. ... the discussion of dealing with excess skin oil. “Oily skin is a challenge to many ... help remove the oily shine while keeping the skin fresh and clean,” says Dr. Au. ...
(Date:3/28/2017)... Davis, California (PRWEB) , ... March 28, 2017 , ... Bacteria and fungi are probably ... all microorganisms are bad. In fact, including the right microorganisms in your diet can actually ... your favorite foods. , This is the topic of a new peer-reviewed paper ...
(Date:3/27/2017)... (PRWEB) , ... March 27, 2017 , ... New patients ... to replace their missing teeth can now have them placed by Dr. Manju Kejriwal, ... latest i-CAT® Cone Beam technology to increase the accuracy of each dental implant placement. ...
(Date:3/27/2017)... ... March 27, 2017 , ... A study by the founder of the ... Sudeep Roy, MD, was recently published in the American Journal of Cosmetic Surgery. “The ... Buckingham and Roy’s study on the use of Electro Lube during the facelift procedure. ...
Breaking Medicine News(10 mins):
(Date:3/27/2017)... NEW YORK , March 27, 2017 ... mixed colors as the NASDAQ Composite closed the trading ... 0.29% lower; and the S&P 500 was down 0.08%. ... of nine sectors finishing the day in green. Pre-market ... stocks: Wright Medical Group N.V. (NASDAQ: WMGI), Amedica Corporation ...
(Date:3/27/2017)... and BOSTON , March 27, ... global pharmaceutical company and Paratek Pharmaceuticals, Inc. (Nasdaq: ... and commercialization of innovative therapies based upon tetracycline ... of sarecycline for the treatment of moderate to ... endpoints. Sarecycline is a once-daily, oral, narrow spectrum ...
(Date:3/27/2017)... -- Impax Laboratories, Inc. (NASDAQ: IPXL)today announced that its Board ... as Impax,s President and Chief Executive Officer and a ... Mr. Bisaro will succeed J. Kevin Buchi , ... Officer since December of 2016. With ... Bisaro, 56, is an accomplished global business leader who ...
Breaking Medicine Technology: